Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Fen Chen, Liu Wang, Xuejia Zhai, Nanxi Wang, Yanjie Qin, Chaoran Zhu, Sanlan Wu & Yongning Lu. (2022) Effect of capsaicin on breast cancer resistance protein (BCRP/Abcg2) and pharmacokinetics of probe substrates in rats. Xenobiotica 52:2, pages 209-217.
Read now
Read now
Katarzyna Niebudek, Ewa Balcerczak, Marek Mirowski, Jacek Pietrzak, Izabela Zawadzka & Marta Żebrowska-Nawrocka. (2019) The contribution of ABCG2 G34A and C421A polymorphisms to multiple myeloma susceptibility. OncoTargets and Therapy 12, pages 1655-1660.
Read now
Read now
Rene Christena Lowrence, Selva Ganesan Subramaniapillai, Venkatasubramanian Ulaganathan & Saisubramanian Nagarajan. (2019) Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells. Critical Reviews in Microbiology 45:3, pages 334-353.
Read now
Read now
Kyoko Fujita & Kimiyoshi Ichida. (2018) ABCG2 as a therapeutic target candidate for gout. Expert Opinion on Therapeutic Targets 22:2, pages 123-129.
Read now
Read now
Katie McFaul, Neill Liptrott, Alison Cox, Phillip Martin, Deirdre Egan, Andrew Owen, Sarah Kelly, Zeenat Karolia, Kate Shaw, Mark Bower & Marta Boffito. (2016) Cytotoxic chemotherapy and the evolution of cellular and viral resistance to antiretroviral therapy in HIV- infected individuals with lymphoma. HIV Clinical Trials 17:5, pages 197-203.
Read now
Read now
Iben Kümler, Jan Stenvang, José Moreira, Nils Brünner & Dorte Lisbet Nielsen. (2015) Drug transporters in breast cancer: response to anthracyclines and taxanes. Expert Review of Anticancer Therapy 15:9, pages 1075-1092.
Read now
Read now
Christopher S Hong, Winson Ho, Chao Zhang, Chunzhang Yang, J Bradley Elder & Zhengping Zhuang. (2015) LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential. Cancer Biology & Therapy 16:6, pages 821-833.
Read now
Read now
Articles from other publishers (55)
Nimisha, Sundeep Singh Saluja, Abhay Kumar Sharma, Phani Kumar Nekarakanti, Apurva, Arun Kumar, Real Sumayya Abdul Sattar, Hasib Anjum, Vineeta Vijay Batra & Syed Akhtar Husain. (2023) Molecular aspects of ABCB1 and ABCG2 in Gallbladder cancer and its clinical relevance. Molecular and Cellular Biochemistry.
Crossref
Crossref
Otis W. Brawley. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
9
.
Chung-Pu Wu, Cheng-Yu Hung, Megumi Murakami, Yu-Shan Wu, Chun-Ling Lin, Yang-Hui Huang, Tai-Ho Hung, Jau-Song Yu & Suresh Ambudkar. (2022) P-glycoprotein Mediates Resistance to the Anaplastic Lymphoma Kinase Inhibitor Ensartinib in Cancer Cells. Cancers 14:9, pages 2341.
Crossref
Crossref
Robert W. Robey, Sabrina Lusvarghi, Cindy H. Chau, Agnes Basseville, William D. Figg, Suresh V. Ambudkar & Susan E. Bates. 2022. Drug Transporters. Drug Transporters
235
256
.
Archita Venugopal Menon & Jonghan Kim. (2022) Iron Promotes Cardiac Doxorubicin Retention and Toxicity Through Downregulation of the Mitochondrial Exporter ABCB8. Frontiers in Pharmacology 13.
Crossref
Crossref
Eliza R. McColl, Vessela Vassileva & Micheline Piquette-Miller. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
608
626
.
Shoji Kokubo, Shinobu Ohnuma, Megumi Murakami, Haruhisa Kikuchi, Shota Funayama, Hideyuki Suzuki, Taiki Kajiwara, Akihiro Yamamura, Hideaki Karasawa, Norihiko Sugisawa, Kosuke Ohsawa, Kuniyuki Kano, Junken Aoki, Takayuki Doi, Takeshi Naitoh, Suresh V. Ambudkar & Michiaki Unno. (2021) A Phenylfurocoumarin Derivative Reverses ABCG2-Mediated Multidrug Resistance In Vitro and In Vivo. International Journal of Molecular Sciences 22:22, pages 12502.
Crossref
Crossref
Chung-Pu Wu, Yan-Qing Li, Tai-Ho Hung, Yu-Tzu Chang, Yang-Hui Huang & Yu-Shan Wu. (2021) Sophoraflavanone G Resensitizes ABCG2-Overexpressing Multidrug-Resistant Non-Small-Cell Lung Cancer Cells to Chemotherapeutic Drugs. Journal of Natural Products 84:9, pages 2544-2553.
Crossref
Crossref
Adil Ali Sayyed, Piyush Gondaliya, Mukund Mali, Abhijeet Pawar, Palak Bhat, Amit Khairnar, Neha Arya & Kiran Kalia. (2021) MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer. Molecular Pharmaceutics 18:8, pages 3010-3025.
Crossref
Crossref
Zahid Hussain, Muhammad Abdur Rahim, Nasrullah Jan, Hassan Shah, Mutasem Rawas-Qalaji, Shahzeb Khan, Mohammad Sohail, Hnin Ei Thu, Nor Amlizan Ramli, Rai Muhammad Sarfraz & Mohammed A.S. Abourehab. (2021) Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy. Journal of Controlled Release 335, pages 130-157.
Crossref
Crossref
Chung-Pu Wu, Cheng-Yu Hung, Sabrina Lusvarghi, Yen-Fu Chang, Sung-Han Hsiao, Yang-Hui Huang, Tai-Ho Hung, Jau-Song Yu & Suresh. V. Ambudkar. (2021) Overexpression of Human ABCB1 and ABCG2 Reduces the Susceptibility of Cancer Cells to the Histone Deacetylase 6-Specific Inhibitor Citarinostat. International Journal of Molecular Sciences 22:5, pages 2592.
Crossref
Crossref
Silpa Narayanan, Nehaben A. Gujarati, Jing-Quan Wang, Zhuo-Xun Wu, Jagadish Koya, Qingbin Cui, Vijaya L. Korlipara, Charles R. AshbyJr.Jr. & Jr. Chen. (2021) The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter. International Journal of Molecular Sciences 22:5, pages 2463.
Crossref
Crossref
Chiharu Sogawa, Takanori Eguchi, Yuri Namba, Yuka Okusha, Eriko Aoyama, Kazumi Ohyama & Kuniaki Okamoto. (2021) Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer. Cells 10:2, pages 344.
Crossref
Crossref
María Ángeles Pena, Javier Muriel, Miriam Saiz-Rodríguez, Alberto M. Borobia, Francisco Abad-Santos, Jesús Frías & Ana M. Peiró. (2020) Effect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib Pharmacokinetics After Single-Dose Administration to Healthy Subjects. Clinical Drug Investigation 40:7, pages 617-628.
Crossref
Crossref
Chung-Pu Wu, Sabrina Lusvarghi, Sung-Han Hsiao, Te-Chun Liu, Yan-Qing Li, Yang-Hui Huang, Tai-Ho Hung & Suresh V. Ambudkar. (2020) Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs. Journal of Natural Products 83:5, pages 1461-1472.
Crossref
Crossref
Sophie E. B. Ambjørner, Michael Wiese, Sebastian Christoph Köhler, Joen Svindt, Xamuel Loft Lund, Michael Gajhede, Lasse Saaby, Birger Brodin, Steffen Rump, Henning Weigt, Nils Brünner & Jan Stenvang. (2020) The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP. Cells 9:3, pages 613.
Crossref
Crossref
Chung-Pu Wu, Sung-Han Hsiao, Yang-Hui Huang, Lang-Cheng Hung, Yi-Jou Yu, Yu-Tzu Chang, Tai-Ho Hung & Yu-Shan Wu. (2020) Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs. Cancers 12:1, pages 195.
Crossref
Crossref
Guohua An & Marilyn E. Morris. 2020. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy
67
96
.
Chung-Pu Wu, Sabrina Lusvarghi, Jyun-Cheng Wang, Sung-Han Hsiao, Yang-Hui Huang, Tai-Ho Hung & Suresh V. Ambudkar. (2019) The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. International Journal of Molecular Sciences 21:1, pages 238.
Crossref
Crossref
Maushmi S. Kumar, Tanuja T. Yadav, Rohan R. Khair, Godefridus J. Peters & Mayur C. Yergeri. (2019) Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment. Current Pharmaceutical Design 25:31, pages 3323-3338.
Crossref
Crossref
Chung-Pu Wu, Sabrina Lusvarghi, Jyun-Cheng Wang, Sung-Han Hsiao, Yang-Hui Huang, Tai-Ho Hung & Suresh V. Ambudkar. (2019) Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines. Molecular Pharmaceutics 16:7, pages 3040-3052.
Crossref
Crossref
Hsiao‐Chi Tsai, An‐Chen Chang, Chun‐Hao Tsai, Yuan‐Li Huang, Lijun Gan, Chi‐Kuan Chen, Shih‐Chia Liu, Te‐Yang Huang, Yi‐Chin Fong & Chih‐Hsin Tang. (2018) CCN2 promotes drug resistance in osteosarcoma by enhancing ABCG2 expression. Journal of Cellular Physiology 234:6, pages 9297-9307.
Crossref
Crossref
Daniel de Klerk, Richard Honeywell, Gerrit Jansen & Godefridus Peters. (2018) Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance. Cancers 10:12, pages 503.
Crossref
Crossref
Shao-hsuan Wen, Shey-chiang Su, Bo-huang Liou, Cheng-hao Lin & Kuan-rong Lee. (2018) Sulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cells. Cancer Cell International 18:1.
Crossref
Crossref
Yuri Namba, Chiharu Sogawa, Yuka Okusha, Hotaka Kawai, Mami Itagaki, Kisho Ono, Jun Murakami, Eriko Aoyama, Kazumi Ohyama, Jun-ichi Asaumi, Masaharu Takigawa, Kuniaki Okamoto, Stuart K. Calderwood, Ken-ichi Kozaki & Takanori Eguchi. (2018) Depletion of Lipid Efflux Pump ABCG1 Triggers the Intracellular Accumulation of Extracellular Vesicles and Reduces Aggregation and Tumorigenesis of Metastatic Cancer Cells. Frontiers in Oncology 8.
Crossref
Crossref
Chung-Pu Wu, Megumi Murakami, Sung-Han Hsiao, Te-Chun Liu, Ni Yeh, Yan-Qing Li, Tai-Ho Hung, Yu-Shan Wu & Suresh. V. Ambudkar. (2018) SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines. Cancer Letters 433, pages 259-272.
Crossref
Crossref
Chung-Pu Wu, Ya-Ju Hsieh, Megumi Murakami, Shahrooz Vahedi, Sung-Han Hsiao, Ni Yeh, An-Wei Chou, Yan-Qing Li, Yu-Shan Wu, Jau-Song Yu & Suresh V. Ambudkar. (2018) Human ATP-binding cassette transporters ABCB1 and ABCG2 confer resistance to histone deacetylase 6 inhibitor ricolinostat (ACY-1215) in cancer cell lines. Biochemical Pharmacology 155, pages 316-325.
Crossref
Crossref
Ni Ai & Xiaohui Fan. 2018. Computational Toxicology. Computational Toxicology
93
120
.
Abril Marcela Herrera-Solorio, Leonel Armas-López, Oscar Arrieta, Joaquín Zúñiga, Patricia Piña-Sánchez & Federico Ávila-Moreno. (2017) Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response. Clinical Epigenetics 9:1.
Crossref
Crossref
Chung-Pu Wu, Sung-Han Hsiao, Megumi Murakami, Ming-Jie Lu, Yan-Qing Li, Chia-Hung Hsieh, Suresh.V. Ambudkar & Yu-Shan Wu. (2017) Tyrphostin RG14620 selectively reverses ABCG2-mediated multidrug resistance in cancer cell lines. Cancer Letters 409, pages 56-65.
Crossref
Crossref
Dorte Lisbet Nielsen, Jesper Palshof, Nils Brünner, Jan Stenvang & Birgitte Martine Viuff. (2017) Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review. International Journal of Molecular Sciences 18:9, pages 1926.
Crossref
Crossref
Chung-Pu Wu, Sung-Han Hsiao, Megumi Murakami, Yu-Jen Lu, Yan-Qing Li, Yang-Hui Huang, Tai-Ho Hung, Suresh. V. Ambudkar & Yu-Shan Wu. (2017) Alpha-Mangostin Reverses Multidrug Resistance by Attenuating the Function of the Multidrug Resistance-Linked ABCG2 Transporter. Molecular Pharmaceutics 14:8, pages 2805-2814.
Crossref
Crossref
Matthew J. Foulkes, Katherine M. Henry, Julien Rougeot, Edward Hooper-Greenhill, Catherine A. Loynes, Phil Jeffrey, Angeleen Fleming, Caroline O. Savage, Annemarie H. Meijer, Simon Jones & Stephen A. Renshaw. (2017) Expression and regulation of drug transporters in vertebrate neutrophils. Scientific Reports 7:1.
Crossref
Crossref
Chung-Pu Wu, Megumi Murakami, Sung-Han Hsiao, An-Wei Chou, Yan-Qing Li, Yang-Hui Huang, Tai-Ho Hung & Suresh. V. Ambudkar. (2017) Overexpression of ATP-Binding Cassette Subfamily G Member 2 Confers Resistance to Phosphatidylinositol 3-Kinase Inhibitor PF-4989216 in Cancer Cells. Molecular Pharmaceutics 14:7, pages 2368-2377.
Crossref
Crossref
Wei Lian, Li Zhang, Long Yang & Wensheng Chen. (2017) AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway. Apoptosis 22:7, pages 933-941.
Crossref
Crossref
Ivette F. Emery, Archana Gopalan, Stephanie Wood, Kin-hoe Chow, Chiara Battelli, Joshy George, Hagen Blaszyk, Jeffrey Florman & Kyuson Yun. (2017) Expression and function of ABCG2 and XIAP in glioblastomas. Journal of Neuro-Oncology 133:1, pages 47-57.
Crossref
Crossref
Raafat El-Awady, Ekram Saleh, Amna Hashim, Nehal Soliman, Alaa Dallah, Azza Elrasheed & Ghada Elakraa. (2017) The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy. Frontiers in Pharmacology 7.
Crossref
Crossref
Fedor V. Moiseenko, Nikita Volkov, Alexey Bogdanov, Michael Dubina & Vladimir Moiseyenko. (2017) Resistance mechanisms to drug therapy in breast cancer and other solid tumors: An opinion. F1000Research 6, pages 288.
Crossref
Crossref
Zachary D. Nagel, Gaspar J. Kitange, Shiv K. Gupta, Brian A. Joughin, Isaac A. Chaim, Patrizia Mazzucato, Douglas A. Lauffenburger, Jann N. Sarkaria & Leona D. Samson. (2017) DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme. Cancer Research 77:1, pages 198-206.
Crossref
Crossref
Agnieszka Sobecka, Wojciech Barczak & Wiktoria Maria Suchorska. (2016) Interferencja RNA w terapii genowej nowotworów rejonu głowy i szyi. Letters in Oncology Science 13:3, pages 64-72.
Crossref
Crossref
Tomohiro Terada. (2016) Pharmaceutical Investigation for Individualized and Optimal Cancer Pharmacotherapyがん薬物療法の個別化・適正化に関する研究. YAKUGAKU ZASSHI 136:11, pages 1469-1476.
Crossref
Crossref
Laura László, Balázs Sarkadi & Tamás Hegedűs. (2016) Jump into a New Fold—A Homology Based Model for the ABCG2/BCRP Multidrug Transporter. PLOS ONE 11:10, pages e0164426.
Crossref
Crossref
Anna Spindler, Katja Stefan & Michael Wiese. (2016) Synthesis and Investigation of Tetrahydro-β-carboline Derivatives as Inhibitors of the Breast Cancer Resistance Protein (ABCG2). Journal of Medicinal Chemistry 59:13, pages 6121-6135.
Crossref
Crossref
Cosimo Marcello Bruno, Gabriele Pricoco, Damiano Cantone, Elisa Marino & Francesca Bruno. (2016) Tubular Handling of Uric Acid and Factors Influencing Its Renal Excretion: A Short Review. EMJ Nephrology, pages 92-97.
Crossref
Crossref
Koji Fukuda, Shimazu Shimazu & Taichi Yoshida. (2016) Application of therapeutic drug monitoring of imatinib for individual treatment of gastrointestinal stromal tumor. International Journal of Cancer Therapy and Oncology 4:2, pages 4211.
Crossref
Crossref
Chung-Pu Wu, Ya-Ju Hsieh, Sung-Han Hsiao, Ching-Ya Su, Yan-Qing Li, Yang-Hui Huang, Chiun-Wei Huang, Chia-Hung Hsieh, Jau-Song Yu & Yu-Shan Wu. (2016) Human ATP-Binding Cassette Transporter ABCG2 Confers Resistance to CUDC-907, a Dual Inhibitor of Histone Deacetylase and Phosphatidylinositol 3-Kinase. Molecular Pharmaceutics 13:3, pages 784-794.
Crossref
Crossref
Aysegul Cort, Tomris Ozben, Luciano Saso, Chiara De Luca & Liudmila Korkina. (2016) Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants. Oxidative Medicine and Cellular Longevity 2016, pages 1-17.
Crossref
Crossref
R. Klopfleisch, B. Kohn & A.D. Gruber. (2016) Mechanisms of tumour resistance against chemotherapeutic agents in veterinary oncology. The Veterinary Journal 207, pages 63-72.
Crossref
Crossref
Agnes Basseville, Matthew D. Hall, Cindy H. Chau, Robert W. Robey, Michael Gottesman, William D. Figg & Susan E. Bates. 2016. ABC Transporters - 40 Years on. ABC Transporters - 40 Years on
195
226
.
Xueqin Chen, Dadong Chen, Shaoyu Yang, Ruobing Ma, Yuelong Pan, Xin Li & Shenglin Ma. (2015) Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients. Cancer Cell International 15:1.
Crossref
Crossref
Christy C. Bridges, Rudolfs K. Zalups & Lucy Joshee. (2015) Toxicological significance of renal Bcrp: Another potential transporter in the elimination of mercuric ions from proximal tubular cells. Toxicology and Applied Pharmacology 285:2, pages 110-117.
Crossref
Crossref
Takahiro Yamaguchi, Tomoko Kurita, Kazuto Nishio, Junichi Tsukada, Toru Hachisuga, Yasuo Morimoto, Yoshiko Iwai & Hiroto Izumi. (2015) Expression of BAF57 in ovarian cancer cells and drug sensitivity. Cancer Science 106:4, pages 359-366.
Crossref
Crossref
Lalit Mohan Negi, Manu Jaggi, Vidushi Joshi, Kar Ronodip & Sushama Talegaonkar. (2015) Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer. International Journal of Biological Macromolecules 73, pages 222-235.
Crossref
Crossref
Anne T. Nies, Tarek Magdy, Matthias Schwab & Ulrich M. Zanger. 2015. ABC Transporters and Cancer. ABC Transporters and Cancer
217
243
.
Ken A. Witt & Karin E. Sandoval. 2014. Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders. Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders
361
390
.